Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in cancer cell proliferation. Shows potential in the development of anti-tumor agents due to its ability to modulate signaling pathways. Also employed in the design of novel heterocyclic compounds for drug discovery programs focused on inflammatory diseases and central nervous system disorders. Its structure supports high binding affinity to specific enzyme active sites, making it valuable in optimizing lead compounds for improved potency and selectivity.